RWE and HTA – a snapshot of recent developments with Sreeram Ramagopalan: March–May 2023

Written by Sreeram Ramagopalan (Lane Clark & Peacock)
Guest columns Health technology assessment Industry Updates Interviews Journal articles Real-world evidence Trial methodologies

Read highlights from the latest instalment of Sreeram Ramagopalan’s (Lane Clark & Peacock, UK) industry news round-up, which discusses some of the latest developments regarding real-world evidence (RWE) in the context of health technology assessment (HTA) and is published bi-monthly in our partner journal, the Journal of Comparative Effectiveness Research. Read the full update for March–May 2023 in the Journal of Comparative Effectiveness Research here >>> What happened over these months that you were expecting? The publication of the final results from RCT-DUPLICATE. This study aimed to ascertain the level of agreement between randomized controlled trial (RCT) results and a...

To view this content, please register now for access

It's completely free